2,7-Dichloro-4,8-dimethylquinoline

Catalog No.: 
ACTUVX633
CAS No.: 
326481-08-7
Molecular Formula: 
C11H9Cl2N
Molecular Weight: 
226.11
2,7-Dichloro-4,8-dimethylquinoline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$153.00InquiryInquiry
1g97%$456.00InquiryInquiry
5g97%$2234.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,7-Dichloro-4,8-dimethylquinoline
IUPAC Name2,7-dichloro-4,8-dimethylquinoline
Molecular FormulaC11H9Cl2N
Molecular Weight226.11
SMILESCC1=C2N=C(Cl)C=C(C)C2=CC=C1Cl
InChI KeyMDFVDASRXQFAFT-UHFFFAOYSA-N
Synonym2,7-Dichloro-4,8-dimethyl-quinoline;Quinoline, 2,7-dichloro-4,8-dimethyl-
CAS No.326481-08-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACTUVX633 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5In Stock
  4. Then
  5. ACTUVX633 route product structure diagram
    ACTUVX633326481-08-7
Inquiry

2. ACTUVX633 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5In Stock
  4. Then
  5. ACTUVX633 route product structure diagram
    ACTUVX633326481-08-7
Inquiry

3. ACTUVX633 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5In Stock
  4. Then
  5. ACTUVX633 route product structure diagram
    ACTUVX633326481-08-7
Inquiry

Comments (0)